Yang, G., Zhuang, L., Sun, T., Yeo, Y. H., Tao, L., Zhang, W., . . . Liu, C. (2022). Serum glial cell line-derived neurotrophic factor (sGDNF) is a novel biomarker in predicting cirrhosis in patients with chronic hepatitis B. Canadian journal of gastroenterology & hepatology, 2022, . https://doi.org/10.1155/2022/1048104
Chicago-Zitierstil (17. Ausg.)Yang, Guangyue, et al. "Serum Glial Cell Line-derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B." Canadian Journal of Gastroenterology & Hepatology 2022 (2022). https://doi.org/10.1155/2022/1048104.
MLA-Zitierstil (9. Ausg.)Yang, Guangyue, et al. "Serum Glial Cell Line-derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B." Canadian Journal of Gastroenterology & Hepatology, vol. 2022, 2022, https://doi.org/10.1155/2022/1048104.